120 related articles for article (PubMed ID: 16714396)
1. Survivin promoter polymorphism and cervical carcinogenesis.
Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
[TBL] [Abstract][Full Text] [Related]
2. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
3. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.
Su TH; Chang TY; Lee YJ; Chen CK; Liu HF; Chu CC; Lin M; Wang PT; Huang WC; Chen TC; Yang YC
Carcinogenesis; 2007 Jun; 28(6):1237-40. PubMed ID: 17341658
[TBL] [Abstract][Full Text] [Related]
5. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
Cheng ZJ; Hu LH; Huang SJ
Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
[TBL] [Abstract][Full Text] [Related]
6. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
[TBL] [Abstract][Full Text] [Related]
7. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
Wagner M; Schmelz K; Dörken B; Tamm I
Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
[TBL] [Abstract][Full Text] [Related]
10. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
[TBL] [Abstract][Full Text] [Related]
15. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
16. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
[TBL] [Abstract][Full Text] [Related]
17. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
[TBL] [Abstract][Full Text] [Related]
20. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
